Search

Displaying results 11 - 20 of 5456 in total
  1. Drug

    Panax notoginseng root

    go.drugbank.com/drugs/DB14304
    Investigational

    It is not an approved drug.

    Synonyms: Notoginseng Radix Et Rhizoma
  2. Pathway

    Ondansetron Predicted Metabolism Pathway

    smpdb.ca/view/SMP0174690
    Metabolic

    Metabolites of Ondansetron are predicted with biotransformer.

    Drugs: Ondansetron · Mesoheme
  3. Pathway

    Ondansetron Serotonin antagonist Action Pathway

    smpdb.ca/view/SMP0126768
    Drug action

    The peripheral actions of ondansetron are thought to be the predominant mechanism for its antiemetic effects. … Ondansetron also has effects peripherally by acting on the vagus nerve. It works on the 5-HT3 receptors that can be found at the vagus nerve terminals.

    Drugs: Pyridoxal phosphate · Tryptophan · Sapropterin · Ondansetron · Calcium · Iron +1 more
  4. Drug

    Rehmannia glutinosa root

    go.drugbank.com/drugs/DB14290
    Investigational

    It is not an approved drug.

    Synonyms: Rehmanniae Preparata Radix Et Ehizoma
  5. Drug

    Methylprednisolone

    go.drugbank.com/drugs/DB00959
    ApprovedInvestigationalVet approved

    [A188811] It was first described in the literature in the late 1950s.[A188811,A188814] Methylprednisolone was granted FDA approval on 24 October 1957.

    Mixtures: Physicians EZ Use M-pred, Physicians EZ Use M-predProducts: METILPREDNISOLONE EG, URBASON 8MG
  6. Drug

    Turmeric

    go.drugbank.com/drugs/DB14276
    ApprovedInvestigational

    It is not an approved drug.

    Synonyms: Curcumarum Tuber Et Radix (Curcuma Longa)
  7. Drug

    Silodosin

    go.drugbank.com/drugs/DB06207
    ApprovedInvestigational

    It is indicated for the symptomatic treatment of benign prostatic hyperplasia in adults. … [A231159] Silodosin was first approved by the FDA in October 2008 [A231159] and it is also approved in Europe and Canada.

    Products: SILODOSINA EG, SILBESAN 8MG HKP
  8. Drug

    Fluvastatin

    go.drugbank.com/drugs/DB01095
    ApprovedInvestigational

    It is also the first entirely synthetic HMG-CoA reductase inhibitor and is structurally distinct from the fungal derivatives of this therapeutic class. … HMG-CoA reductase catalyzes the conversion of HMG-CoA to mevalonic acid, the rate-limiting step in cholesterol biosynthesis.

    Products: FLUVASTATIN - CT 80MG RET, FLUVASTATIN - CT 40MG HART
  9. Drug

    Hydromorphone

    go.drugbank.com/drugs/DB00327
    ApprovedIllicitInvestigational

    [A176471] Even though hydromorphone does not present a 6-hydroxyl group, it is categorized under the family of phenanthrenes and it is considered a chemical under the schedule II (medical purposes with … Due to these modifications, it presents a very high potency and comparable side effect profile to the parent compound.

    Products: JURNISTA 4MG RET, HYDROMORPHON AL 4MG RET
  10. Drug

    Ropinirole

    go.drugbank.com/drugs/DB00268
    ApprovedInvestigational

    In 2005, it was the first drug approved in the US for the management of primary moderate to severe restless legs syndrome [A174547]. … It is manufactured by GlaxoSmithKline Pharmaceuticals. Ropinirole was initially approved in 1997 by the FDA [FDA label] for the management of Parkinson's disease.

    Products: ROPINIROL - CT 8MG RET TAB, REQUIP MODUTAB 8MG RET